Irlab Therapeutics Ab operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Irlab Therapeutics Ab with three other
pharmaceutical manufacturers in Europe:
Index Pharmaceuticals Holding Ab
(2017
sales of 113,000.00 Swedish Kronor [US$12,209.65 ]
),
Oasmia Pharmaceutical AB
(172,000.00 Swedish Kronor [US$18,584.60 ]
of which 100%
was Sale of Necessities), and
Infant Bacterial Therapeutics AB
(238,000.00 Swedish Kronor [US$25,715.90 ]
).
Sales Analysis.